Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frishman

Showing results (611-620 of 1,560) with videos related to

Pageof 156
Sort By:
American Heart Journal|June 1, 1994
Intranasal delivery of cardiovascular agents: an innovative approach to cardiovascular pharmacotherapyA J Landau, R T Eberhardt, W H Frishman
Molekuliarnaia Biologiia|September 1, 1990
[G-proteins have a sequence similar to ganglioside-binding hemagglutinins from the influenza virus]D I Frishman, A L Berman, O I Kiselev
Clinical Therapeutics|January 28, 1998
Optimization of antihypertensive therapy with a novel, extended-release formulation of diltiazem: results of a practice-based clinical studyJ M Neutel, D H Smith, W H Frishman
Cardiology in Review|March 24, 2021
Cardiovascular and Cerebrovascular Complications With COVID-19Arielle Greenberg, Gayatri Pemmasani, Srikanth Yandrapalli, et al.
Cardiology in Review|April 17, 2010
Apolipoprotein A-I mimetic peptides: a potential new therapy for the prevention of atherosclerosisCourtney B Sherman, Stephen J Peterson, William H Frishman
Cardiology in Review|June 19, 2007
Cardiovascular drug therapy in the elderlyWilbert S Aronow, William H Frishman, Angela Cheng-Lai
Cardiology in Review|August 11, 2020
Effect of Bariatric Surgery on Cardiovascular Function and Heart Failure OutcomesBeth Hillary Mottel, David Allen Lindsay, William H Frishman
Heart Disease (Hagerstown, Md.)|December 1, 2001
Cardiovascular drug therapy in the elderlyW S Aronow, W H Frishman, A Cheng-Lai
Heart Disease (Hagerstown, Md.)|December 1, 2001
Clopidogrel: a new antiplatelet drugR G Lerner, W H Frishman, K T Mohan
Heart Disease (Hagerstown, Md.)|May 25, 2002
Innovative drug treatments for viral and autoimmune myocarditisWilliam H Frishman, Miechelle O'Brien, Nauman Naseer, et al.
Pageof 156

Showing results (611-620 of 1,560) with videos related to

Sort By:
Pageof 156
American Heart Journal|June 1, 1994
Intranasal delivery of cardiovascular agents: an innovative approach to cardiovascular pharmacotherapyA J Landau, R T Eberhardt, W H Frishman
Molekuliarnaia Biologiia|September 1, 1990
[G-proteins have a sequence similar to ganglioside-binding hemagglutinins from the influenza virus]D I Frishman, A L Berman, O I Kiselev
Clinical Therapeutics|January 28, 1998
Optimization of antihypertensive therapy with a novel, extended-release formulation of diltiazem: results of a practice-based clinical studyJ M Neutel, D H Smith, W H Frishman
Cardiology in Review|March 24, 2021
Cardiovascular and Cerebrovascular Complications With COVID-19Arielle Greenberg, Gayatri Pemmasani, Srikanth Yandrapalli, et al.
Cardiology in Review|April 17, 2010
Apolipoprotein A-I mimetic peptides: a potential new therapy for the prevention of atherosclerosisCourtney B Sherman, Stephen J Peterson, William H Frishman
Cardiology in Review|June 19, 2007
Cardiovascular drug therapy in the elderlyWilbert S Aronow, William H Frishman, Angela Cheng-Lai
Cardiology in Review|August 11, 2020
Effect of Bariatric Surgery on Cardiovascular Function and Heart Failure OutcomesBeth Hillary Mottel, David Allen Lindsay, William H Frishman
Heart Disease (Hagerstown, Md.)|December 1, 2001
Cardiovascular drug therapy in the elderlyW S Aronow, W H Frishman, A Cheng-Lai
Heart Disease (Hagerstown, Md.)|December 1, 2001
Clopidogrel: a new antiplatelet drugR G Lerner, W H Frishman, K T Mohan
Heart Disease (Hagerstown, Md.)|May 25, 2002
Innovative drug treatments for viral and autoimmune myocarditisWilliam H Frishman, Miechelle O'Brien, Nauman Naseer, et al.
Pageof 156